MUMBAI (Reuters) - Ranbaxy Laboratories Ltd has started exports of a copycat version of blockbuster cholesterol drug Lipitor from a new facility in India that has been approved by the U.S. Food and Drug Administration.
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/_kFPq2VMynw/us-ranbaxy-lipitor-india-idUSBRE83107L20120402
recent news save money travel make money best news online money
No comments:
Post a Comment